Posatex
orbifloxacin / mometasone furoate / posaconazole
Table of contents
Overview
Posatex is a veterinary medicine used to treat dogs that suffer from acute or recurrent episodes of ear infections (otitis externa) caused by bacteria or fungi. It contains the active substances orbifloxacin, mometasone furoate and posaconazole.
Authorisation details
Product details | |
---|---|
Name |
Posatex
|
Agency product number |
EMEA/V/C/000122
|
Active substance |
|
International non-proprietary name (INN) or common name |
|
Species |
Dogs
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QS02CA91
|
Publication details | |
---|---|
Marketing-authorisation holder |
Intervet International BV
|
Revision |
9
|
Date of issue of marketing authorisation valid throughout the European Union |
23/06/2008
|
Contact address |
Wim de Körverstraat 35
5831 AN Boxmeer The Netherlands |
Product information
14/05/2013 Posatex - EMEA/V/C/000122 - II/0028/G
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Otologicals
Therapeutic indication
Treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular Malassezia pachydermatis.